JAMIE GARCIA: Open Payments
NPI 1760638712 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 17 payments from 7 companies in 2025. Trend: 2023 $30,873 · 2024 $9,137 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $201 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| ABBVIE INC. | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: INGREZZA, INVEGA SUSTENNA, UZEDY, CAPLYTA, AUSTEDO XR, VRAYLAR, Xelstrym, HETLIOZ.
Industry payments across CA — which companies pay providers there.
